The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The India intravenous solution market is currently witnessing moderate growth. Intravenous (IV) solutions are a mix of essential nutrients that replenish fluid loss and treat electrolyte imbalances in IV therapy. They are administered into the venous circulation with the help of a syringe or IV catheter. IV solutions are made of electrolytes, sugar, and medications required by patients suffering from diabetes, cancer and other diseases. They also provide nutrients added in concentrations as per the patient’s medical condition, age, and size.
India represents one of the largest markets for IV solutions, primarily driven by the increasing population and the rising prevalence of gastrointestinal diseases, neurological disorders, and diabetes. This is due to unhealthy eating habits and sedentary lifestyles. Besides this, various government initiatives related to improving the healthcare infrastructure of the country are also propelling the growth of the market. Additionally, the growing consciousness among individuals regarding their health and the increasing disposable incomes of consumers have enabled them to expand healthcare expenditure, thereby positively impacting the market growth. Furthermore, the availability of these solutions in portable packages has made it easier for patients to use drips in their home’s comfort. On account of these factors, the market is expected to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the India intravenous solution market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
Breakup by Nutrients:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at